Filter
2651
Filtered Results: 2651
Text search:
Medical
Products
Management
and
Regulation
Featured
Recommendations
273
New Publications
759
Language
Document type
No document type
1377
Studies & Reports
437
Guidelines
424
Manuals
191
Strategic & Response Plan
143
Training Material
29
Fact sheets
24
Situation Updates
16
Resource Platforms
6
Infographics
3
Online Courses
1
Countries / Regions
Global
112
Kenya
94
India
88
Sierra Leone
68
Western and Central Europe
65
Nigeria
61
Liberia
60
South Africa
57
Ghana
48
Uganda
46
Ethiopia
45
Zambia
39
Nepal
38
Africa
37
Latin America and the Carribbean
37
Rwanda
36
Tanzania
33
Bangladesh
33
Malawi
31
Myanmar / Burma
31
Ukraine
29
Philippines
29
Syria
26
Namibia
26
South–East Asia Region
24
Congo, Democratic Republic of
23
Eastern Europe
21
Zimbabwe
17
Asia
17
West and Central Africa
17
Indonesia
17
Lesotho
16
Guinea
16
Senegal
15
Cambodia
15
Eastern Europe and Central Asia
14
Eswatini/ Swaziland
14
East and Southern Africa
13
Pakistan
12
Botswana
11
Haiti
10
Western Pacific Region
10
Cameroon
9
Mozambique
9
Middle East and North Africa
9
South Sudan
9
Burkina Faso
8
Thailand
7
USA
7
Jordan
7
Lebanon
7
Moldova
7
Yemen
7
Colombia
6
Turkey
6
Afghanistan
6
Venezuela
6
Brazil
6
Russia
6
Sudan
6
Iraq
6
Laos
5
Georgia
5
North Macedonia
4
Tajikistan
4
Albania
4
Germany
4
Argentina
4
Vietnam
4
Mali
4
Somalia
4
Benin
3
China
3
Kazakhstan
3
Iran
3
Kyrgyzstan
3
Saudi Arabia
3
Mauritius
3
Egypt
3
Ecuador
3
Timor Leste/ East Timor
2
El Salvador
2
Chile
2
Fiji
2
Uzbekistan
2
Peru
2
Qatar
2
Croatia
2
Paraguay
2
United Kingdom
2
Bolivia
2
Papua New Guinea
2
Sri Lanka
2
Palestine
2
Central African Republic
2
Chad
2
Libya
2
Bhutan
2
Serbia
1
Australia
1
Gambia
1
Estonia
1
Burundi
1
Morocco
1
Armenia
1
Guinea-Bissau
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Morocco
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Djibouti
1
Romania
1
Greece
1
Poland
1
Honduras
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1006
Clinical Guidelines
192
Public Health
188
Key Resources
179
Women & Child Health
125
Pharmacy & Technologies
60
Capacity Building
35
Toolboxes
COVID-19
208
AMR
156
Mental Health
142
Rapid Response
137
HIV
133
Pharmacy
126
TB
102
Planetary Health
94
Caregiver
88
Ebola & Marburg
81
Conflict
73
Disability
63
Global Health Education
53
NTDs
52
NCDs
44
Specific Hazards
34
Refugee
32
Health Financing Toolbox
31
Natural Hazards
30
Zika
21
Polio
12
Cholera
8
Social Ethics
6
Typhoon
2
Malaria
1
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
The National Strategic Plan is based on the following guiding principles:
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recognizes the cross cutting health and development needs o...
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recognizes the cross cutting health and development needs o...
Sectors in which Priority Adaptation Projects should be implemented first include:
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir...
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
National HIV Strategic Plan 2016-2021
DHS Further Analysis Reports No. 103
Capability and Performance
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Vulnerable and Marginalized Groups Planning Framework
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
